CGIX - Cancer Genetics reports Q4 results June, 01 2020 08:16 AM Cancer Genetics Inc. Cancer Genetics (NASDAQ:CGIX): Q4 GAAP EPS of -$0.14.Revenue of $1.9M (+11.8% Y/Y)Shares +7% PM.Press ReleaseMore news on: Cancer Genetics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,